Jon Riise
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 9
- Genetics 6
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Finn Olav Levy (4 shared papers)Eirik Qvigstad (3 shared papers)Dagny Sandnes (2 shared papers)Martin Hutchings (4 shared papers)Tarec Christoffer El‐Galaly (3 shared papers)J. B. Osnes (1 shared paper)Jacob Haaber Christensen (3 shared papers)Ingrid Cecilia Glimelius (4 shared papers)
In The Last Decade
Jon Riise
15 papers receiving 240 citations
Jon Riise's Hit Papers
Peers
Comparison fields: 5 of 37
- Pathology and Forensic Medicine 134
- Genetics 66
- Oncology 90
- Cardiology and Cardiovascular Medicine 33
- Infectious Diseases 21
Countries citing papers authored by Jon Riise
This map shows the geographic impact of Jon Riise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Riise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Riise more than expected).
Fields of papers citing papers by Jon Riise
This network shows the impact of papers produced by Jon Riise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Riise. The network helps show where Jon Riise may publish in the future.
Co-authors
The 25 scholars most cited alongside Jon Riise, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network Hit paper breakdown → | 2024 | 71 |
| 2 | 2022 | 62 | |
| 3 | 2022 | 28 | |
| 4 | 2023 | 23 | |
| 5 | 2023 | 15 | |
| 6 | 2008 | 13 | |
| 7 | 2012 | 10 | |
| 8 | 2025 | 7 | |
| 9 | 2013 | 6 | |
| 10 | 2025 | 4 | |
| 11 | 2022 | 3 | |
| 12 | 2012 | 2 | |
| 13 | 2025 | 2 | |
| 14 | 2025 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2026 | 0 |
About Jon Riise
Jon Riise is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 16 papers that have together received 248 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Pulmonary Hypertension Research and Treatments (2 papers), Viral-associated cancers and disorders (2 papers), Heart Failure Treatment and Management (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Cancer Genomics and Diagnostics (1 paper) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (134 citations), Genetics (66 citations), Oncology (90 citations), Cardiology and Cardiovascular Medicine (33 citations) and Infectious Diseases (21 citations). Jon Riise has collaborated with scholars based in Norway, Denmark and Sweden. Frequent co-authors include Finn Olav Levy, Eirik Qvigstad, Dagny Sandnes, Martin Hutchings, Tarec Christoffer El‐Galaly, J. B. Osnes, Jacob Haaber Christensen, Ingrid Cecilia Glimelius, Tor Skomedal and Carsten Utoft Niemann. Their work appears in journals such as The Lancet, Blood Advances, Blood, Cardiovascular Research and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.